Anika Therapeutics Inc (ANIK)

May 05, 2026

Insider Buying: HENNEMAN JOHN B III Acquires 5,000 Shares of Ani - GuruFocus

May 05, 2026

May 05, 2026

Anika maintains 2026 revenue guidance of $114M-$122.5M while highlighting Integrity growth and Hyalofast FDA response work - MSN

May 05, 2026

May 05, 2026

Anika Therapeutics Q1 2026 earnings preview - MSN

May 05, 2026

May 04, 2026

Anika Therapeutics director John Henneman buys $73,319 in shares By Investing.com - Investing.com Canada

May 04, 2026

May 04, 2026

Anika Therapeutics director John Henneman buys $73,319 in shares - Investing.com

May 04, 2026

May 04, 2026

Anika Therapeutics (ANIK) director adds 5,000 shares in open-market buy - Stock Titan

May 04, 2026

May 03, 2026

President of Anika Therapeutics Picks Up 51% More Stock - Yahoo Finance

May 03, 2026

May 02, 2026

Anika Therapeutics (NASDAQ:ANIK) Rating Lowered to "Buy" at Wall Street Zen - MarketBeat

May 02, 2026

May 01, 2026

ANIK | Anika Therapeutics Inc Insider Trading - Quiver Quantitative

May 01, 2026

May 01, 2026

Anika Therapeutics Projects $114 Million Revenue Growth for Fiscal 2026 - HarianBasis.co

May 01, 2026

Apr 30, 2026

Insider Buying: Stephen Griffin Acquires Shares of Anika Therape - GuruFocus

Apr 30, 2026

Apr 30, 2026

Anika Therapeutics (NASDAQ:ANIK) CEO Purchases $149,938.00 in Stock - MarketBeat

Apr 30, 2026

Apr 30, 2026

Anika Therapeutics Q1 2026 Financial Results: Revenue, Losses, and Key Financial Statements Overview - Minichart

Apr 30, 2026

Apr 30, 2026

Anika Therapeutics’ CEO Stephen Griffin buys $149,880 in company stock By Investing.com - Investing.com India

Apr 30, 2026

Apr 30, 2026

Anika Therapeutics’ CEO Stephen Griffin buys $149,880 in company stock - Investing.com

Apr 30, 2026

Apr 30, 2026

Insider Purchase: President and CEO of $ANIK Buys 12,200 Shares - Quiver Quantitative

Apr 30, 2026

Apr 30, 2026

Anika Therapeutics (ANIK) CEO buys 12,200 shares in open market - Stock Titan

Apr 30, 2026

Apr 30, 2026

Anika Therapeutics : 2026 Proxy Statement - marketscreener.com

Apr 30, 2026

Apr 30, 2026

Bullish On Anika Therapeutics’s Pullback As Integrity Scales (NASDAQ:ANIK) - Seeking Alpha

Apr 30, 2026

Apr 30, 2026

Rotator cuff procedure advances driven by biology, Anika Therapeutics claims - Traders Union

Apr 30, 2026

Apr 30, 2026

(ANIK) and the Role of Price-Sensitive Allocations - Stock Traders Daily

Apr 30, 2026

Apr 30, 2026

Anika Therapeutics, Inc. (NASDAQ:ANIK) Q1 2026 Earnings Call Transcript - Insider Monkey

Apr 30, 2026

Apr 30, 2026

Revenue climbs 13% as Anika Therapeutics (NASDAQ: ANIK) boosts margins but stays in loss - Stock Titan

Apr 30, 2026

Apr 30, 2026

Anika Therapeutics Inc (ANIK) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic Investments - GuruFocus

Apr 30, 2026

Apr 29, 2026

Anika Therapeutics (ANIK) Q4 Profit Challenges Ongoing Unprofitability Narrative Ahead Of Q1 Earnings - simplywall.st

Apr 29, 2026

Apr 29, 2026

Anika Therapeutics Signals Momentum Amid Regulatory Hurdles - TipRanks

Apr 29, 2026

Apr 29, 2026

Vanguard (ANIK) discloses 695,697 shares, a 5.19% stake (Schedule 13G) - Stock Titan

Apr 29, 2026

Apr 29, 2026

Anika Therapeutics (NASDAQ:ANIK) Releases Earnings Results, Misses Expectations By $0.17 EPS - MarketBeat

Apr 29, 2026

Apr 29, 2026

Anika Therapeutics Releases Q1 2026 Financial Results - AlphaStreet

Apr 29, 2026

Apr 29, 2026

Anika Therapeutics Posts Strong Q1 2026 Revenue Growth - TipRanks

Apr 29, 2026

Apr 29, 2026

Earnings Call Summary | Anika Therapeutics(ANIK.US) Q1 2026 Earnings Conference - 富途牛牛

Apr 29, 2026

Apr 29, 2026

12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga

Apr 29, 2026

Apr 29, 2026

Anika (ANIK) Q1 2026 Earnings Transcript - AOL.com

Apr 29, 2026

Apr 29, 2026

Anika Therapeutics, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance

Apr 29, 2026

Apr 29, 2026

ANIK Reports Q1 Revenue Growth Driven by Strong Commercial Chann - GuruFocus

Apr 29, 2026

Apr 29, 2026

Anika Therapeutics Q1 Earnings Call Highlights - MarketBeat

Apr 29, 2026

Apr 29, 2026

Is Anika Therapeutics (ANIK) 30.3% Undervalued After Q1 2026 Ear - GuruFocus

Apr 29, 2026

Apr 29, 2026

Earnings call transcript: Anika Therapeutics Q1 2026 beats EPS forecast By Investing.com - Investing.com Australia

Apr 29, 2026

Apr 29, 2026

Earnings call transcript: Anika Therapeutics Q1 2026 beats EPS forecast - Investing.com

Apr 29, 2026

Apr 29, 2026

Anika Therapeutics, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:ANIK) 2026-04-29 - Seeking Alpha

Apr 29, 2026

Apr 29, 2026

ANIKA THERAPEUTICS ($ANIK) Releases Q1 2026 Earnings - Quiver Quantitative

Apr 29, 2026

Apr 29, 2026

Anika Therapeutics board members William R. Jellison and Glenn R. Larsen resign ahead of 2026 annual meeting - TradingView

Apr 29, 2026

Apr 29, 2026

Double-digit Q1 growth at Anika (NASDAQ: ANIK) as margins rise - Stock Titan

Apr 29, 2026

Apr 29, 2026

Anika: Q1 Earnings Snapshot - 10TV

Apr 29, 2026

Apr 29, 2026

Anika Reports First Quarter 2026 Financial Results - The Manila Times

Apr 29, 2026

Apr 29, 2026

Anika lifts gross margin to 64% as commercial, OEM sales grow - Stock Titan

Apr 29, 2026

Apr 28, 2026

Anika Therapeutics (NASDAQ: ANIK) details 2026 meeting, director votes and larger equity pools - Stock Titan

Apr 28, 2026

Apr 28, 2026

[ARS] Anika Therapeutics, Inc. SEC Filing - Stock Titan

Apr 28, 2026

Apr 27, 2026

Anika Therapeutics ends Shoulder360 weekend by inviting demo requests for Integrity product - Traders Union

Apr 27, 2026

Apr 23, 2026

Integrity Implant System introduced as Anika Therapeutics opens Shoulder360 conference - Traders Union

Apr 23, 2026

Apr 23, 2026

ANIK (Anika Therapeutics Inc.) swings to Q4 2025 profit against expected loss, shares edge higher.Earnings Quality - Xã Châu Thành

Apr 23, 2026

Apr 23, 2026

ANIK (Anika Therapeutics Inc.) posts massive Q4 2025 EPS beat, dips 0.13% in muted investor reaction today.Barrier to Entry - UBND thành phố Hải Phòng

Apr 23, 2026